Stanford study links brain activity patterns to Alzheimer's risk up to 12 years before symptoms

Stanford Medicine researchers report that subtle patterns of brain activity may identify adults at higher risk of Alzheimer's disease up to 12 years before symptoms appear. Published in Science Advances on Nov. 4, the study compared brain activity in adults 75 and older with Alzheimer's disease and in super agers, people at least 75 who scored on memory tests like people about 45 while keeping normal executive function. The team built a scoring system from those opposite ends of cognitive aging.

When applied to cognitively healthy adults aged 55 to 70, the score linked brain activity to later outcomes. Participants whose patterns more closely resembled the Alzheimer's group were more likely to experience cognitive decline, accumulate amyloid-beta plaques and receive an Alzheimer's diagnosis during follow-up lasting as long as 12 years. Those whose patterns resembled super agers were more likely to maintain cognition and avoid those outcomes. The researchers say the score outperformed demographics, genetic risk and amyloid-beta and tau biomarkers.

The finding matters because current Alzheimer's biomarkers often become visible late, after years of neurodegeneration. Yu Zhang, the senior author, framed the work as a search for earlier signs that could guide timely intervention. The approach also points to resilience: about 10% of older adults may qualify as super agers under some definitions, and their brain patterns offer a possible target state for treatment. The study identifies candidate regions and patterns, but it does not prove that altering brain activity can prevent disease.

For families and health systems facing rising dementia, a test that works years before memory loss has direct implications for screening, clinical trials and prevention planning. The proposed interventions, including cognitive training and transcranial magnetic stimulation, have not been tested for this purpose, and researchers do not know whether changing activity would alter Alzheimer's course. The work gives scientists a concrete roadmap: find at-risk brains early, compare them with resilient brains, and define what to target.